Features
Screener
Pricing
Resources
About
en
Features
Screener
Pricing
Resources
About
Language
en
Login
Start for free
DISCOVER
Screener
Stocks
ETF
Crypto
SCPI
Trending
Comparator
Calendar
Charting
Super investors
SOCIAL
Community
Public portfolios
/
Image Modal
Image Modal Description
Shenyang Xingqi Pharmaceutical Co.,Ltd
300573.SZ
-
CNE100002DV1
Compare
Last update : Aug 24, 2026 at 23:20
General
Scores
Financials
Ratios
Valuation
Dividend
Exposure
Analysts
Insider
Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ) Dividend, Growth and Profitability Scores - Invvest
Dividend
Last update : Jul 31, 2026
10
mMrd
Metrics
Value
Rating
Payout ratio
95
6lX9I
apyOo
Free cash flow payout ratio
100
rbNP6
XoVXG
3Y Earnings growth
9
frdvS
irI7L
Dividend streak
48
nIcDQ
a4mYH
Dividend growth streak
69
jGKqI
ncrpa
5Y Dividend growth
26
XOz7s
oik5T
15Y Dividend cut
56
z28F0
SCRe3
15Y Dividend interruption
97
2fCMD
pZQTi
Return on equity
17
1Rbf7
sWWCx
Net debt / EBITDA
28
E0gXK
opwav
Interest coverage
85
euVfN
MPivC
Growth
Last update : Jul 30, 2026
11
cXKrV3H
Metrics
Value
Rating
Revenue growth
73
6Mjyc
22hfP
5Y Revenue growth
85
FsQea
pZt8u
EBITDA growth
46
I5Wq1
Financial Strength
Last update : Jul 30, 2026
7
EXsa5VAF
Metrics
Value
Rating
Interest coverage
75
MvyLp
5AYCO
Quick ratio
38
vwXYi
8A22z
Debt / Assets
24
JUOj5
Profitability
Last update : Jul 30, 2026
17
Jmk
Metrics
Value
Rating
Gross margin
67
gpCA2
vchpC
Operating margin
100
BYkBC
5msct
Net margin
87
gBFC8
PAK1p
Momentum
Last update : Aug 23, 2026
11
LoEEyo
Metrics
ESG
No data available currently
Piotroski F
Last update : Aug 4, 2026
1
Unlock this feature
0
3
6
9
Altman Z
Last update : Aug 4, 2026
1
Unlock this feature
0 and -
1.8
3
4.5 and +
ehadw
5Y EBITDA growth
59
epagv
bAf9a
Operating income growth
48
d1F3a
CDJ6w
5Y Operating income growth
28
QT6o1
Yq0e6
Net income growth
10
SXYZW
us0Iu
Free cash flow growth
9
WIO16
E2pXh
5Y Free cash flow growth
28
Ir6zX
GhWuz
Operating cash flow growth
37
VeHtC
laLww
5Y Operating cash flow growth
48
jNiVt
cZKmV
Capex growth
5
NFuCt
DnM9H
fznfc
Debt / Equity
54
Ln89D
SaChx
Net debt / EBITDA
1
2UmoD
JMHHw
Cash / Debt
37
3xhMm
uMbhO
Altman Z Score
10
YhGVe
gEKYB
Piotroski F Score
23
SFUiW
FPSni
Capex coverage ratio
58
T5X0V
QphyM
Free cash flow margin
76
d2xct
QA1Do
Return on invested capital
17
YFSHq
B7jtF
Return on equity
88
8fYKd
T8b5k
Return on assets
16
TKH1i
KbBHy
Capex / Revenue
71
WLoEm
GtK2X
Profitable years 5Y
64
n54EK
VkOTq
Value
Rating
SMA 50 vs Price
9
8ENrv
cTrKr
SMA 200 vs Price
64
kQOA0
xR5P6
SMA 50 vs SMA 200
24
ilb5q
uV6jO
1M Decile rank
13
Sytd4
njpKP
6M Decile rank
64
VOCdL
cR70R
1Y Decile rank
68
zr9Ja
kxRhc
